About
DIA Labs Canada develops AirSense, a microneedle-based wearable that tracks inflammatory biomarkers in real time to enable early intervention before an asthma attack. The system supports personnel health, reduces medical emergencies, and helps maintain performance during training, deployments, and extreme environmental exposure.
Dual-Use Potential
Continuous biomarker monitoring supports preventive respiratory care across military and civilian healthcare settings. Real-time inflammatory tracking enables early intervention, remote health monitoring, and performance management for personnel operating in high-stress or extreme environments, reducing emergency events and improving medical readiness.
long-arrow-right
